ghk-cu peptide clinical studies 2026: Benefits, Mechanisms, Safety & Evidence GHK-Cu Clinical Profile | Copper

Lesin medular: recuperacin parcial en modelos animales

Patients with a personal or strong family history of certain cancers are not automatically excluded from Epithalon therapy, but the risk-benefit discussion is mandatory before protocol initiation

DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide originally isolated from rabbit brain venous blood, studied in sleep-cycle modulation, stress-response attenuation, and neuroendocrine signalling models

No significant gender differences were observed, though a weak positive correlation with age was noted

GHK-Cu is endogenous to human plasma and has no documented long-term toxicity at therapeutic doses